Boston Scientific secures $455M from Blackstone Life Sciences to co-fund VITALYST heart pump development for cardiogenic shock treatment.
Amount Raised
$455 Million
Round Type
Venture
MarlboroughManufacturingBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Blackstone Life Sciences announced a $455 million collaboration with Boston Scientific Corporation to co-fund development of the VITALYST Temporary Percutaneous Transvalvular Circulatory Support System. The VITALYST system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock by increasing cardiac output and improving blood flow to vital organs. This marks the first co-funding partnership between Boston Scientific and Blackstone Life Sciences for a Boston Scientific product. The collaboration aims to advance a next-generation medical device with improved efficacy, safety, and ease of use.
Who to call at Boston Scientific, and when
A new round usually means Boston Scientific is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Boston Scientific raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Boston Scientific, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Boston Scientific. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Boston Scientific raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Boston Scientific raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.